Topologically inferring risk-active pathways toward precise cancer classification by directed random walk

Bioinformatics

Volumn 29, Issue 17, 2013, Pages 2169-2177

  Liu, Wei ^a,b   Li, Chunquan ^a   Xu, Yanjun ^a   Yang, Haixiu ^a   Yao, Qianlan ^a   Han, Junwei ^a   Shang, Desi ^a   Zhang, Chunlong ^a   Su, Fei ^a   Li, Xia ^a   Li, Xiaoxi ^c   Xiao, Yun ^a   Zhang, Fan ^a   Dai, Meng ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG INSTITUTE OF TECHNOLOGY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CLASSIFICATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; NEOPLASM; REPRODUCIBILITY; RISK; SIGNAL TRANSDUCTION;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84882589554     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt373     Document Type: Article

References (53)

1. Ashburner, M. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
2. Bild, A. H. et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439, 353-357.
3. Brin, S. and Page, L. (1998) The anatomy of a large-scale hypertextual web search engine. Comput. Netw. ISDN Syst., 30, 107-117.
4. Can, T. et al. (2005) Analysis of protein-protein interaction networks using random walks. In: Proceedings of the 5th International Workshop on Bioinformatics. Chicago, Illinois, pp. 61-68.
5. Carter, S. L. et al. (2004) Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics, 20, 2242-2250.
6. Chang, C. and Lin, C. (2011) LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol., 2.
7. Cho, J. H. et al. (2011) Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med. Genomics, 4, 8.
8. Chuma, M. et al. (2004) Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol., 41, 629-636.
9. D'Errico, M. et al. (2009) Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur. J. Cancer, 45, 461-469.
10. Dalgliesh, G. L. et al. (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature, 463, 360-363.
11. Draghici, S. et al. (2007) A systems biology approach for pathway level analysis. Genome Res., 17, 1537-1545.
12. Dupuy, A. and Simon, R. M. (2007) Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J. Natl Cancer Inst., 99, 147-157.
13. Edgar, R. et al. (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
14. Efroni, S. et al. (2007) Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS One, 2, e425.
15. Ein-Dor, L. et al. (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl Acad Sci. USA, 103, 5923-5928.
16. Fan, R. et al. (2008) LIBLINEAR: a library for large linear classification. J. Mach. Learn. Res., 9, 1871-1874.
17. Gao, S. and Wang, X. (2007) TAPPA: topological analysis of pathway phenotype association. Bioinformatics, 23, 3100-3102.
18. Guo, Z. et al. (2005) Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics, 6, 58.
19. Haverstick, D. M. et al. (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2 entry. Cancer Res., 60, 1002-1008.
20. Hayes, D. F. and Thor, A. D. (2002) c-erbB-2 in breast cancer: development of a clinically useful marker. Semin. Oncol., 29, 231-245.
21. Hung, J. H. et al. (2010) Identification of functional modules that correlate with phenotypic difference: the influence of network topology. Genome Biol., 11, R23.
22. Johannes, M. et al. (2010) Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients. Bioinformatics, 26, 2136-2144.
23. Johannes, M. et al. (2011) pathClass: an R-package for integration of pathway knowledge into support vector machines for biomarker discovery. Bioinformatics, 27, 1442-1443.
24. John, G. H. and Langley, P. (1995) Estimating continuous distributions in Bayesian classifiers. In: Proceedings of the Eleventh Conference on Uncertainty in Artificial Intelligence. Morgan Kaufmann Publishers Inc., Montréal, Canada, pp. 338-345.
25. Johnson, E. et al. (2010) HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J. Biol. Chem., 285, 29491-29501.
26. Jones, J. et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin. Cancer Res., 11, 5730-5739.
27. Kanehisa, M. and Goto, S. (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30.
28. Kim, S. et al. (2012) Pathway-based classification of cancer subtypes. Biol. Direct, 7, 21.
29. Kohler, S. et al. (2008) Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet., 82, 949-958.
30. Kuner, R. et al. (2009) Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer, 63, 32-38.
31. Lü, L. et al. (2011) Leaders in social networks, the delicious case. PLoS One, 6, e21202.
32. Landi, M. T. et al. (2008) Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One, 3, e1651.
33. Lee, E. et al. (2008) Inferring pathway activity toward precise disease classification. PLoS Comput. Biol., 4, e1000217.
34. Li, C. et al. (2009) SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res., 37, e131.
35. Li, C. et al. (2013) Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res., 41, e101.
36. Li, Y. and Patra, J. C. (2010) Integration of multiple data sources to prioritize candidate genes using discounted rating system. BMC Bioinformatics, 11 (Suppl. 1), S20.
37. Lovasz, L. (1996) Random walks on graphs: a survey. In: Combinatorics, Paul Erdos is Eighty. Vol. 2, János Bolyai Mathematical Society, pp. 253-398.
38. Lu, X. et al. (2007) Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol. Syst. Biol., 3, 98.
39. Martin, T. A. and Jiang, W. G. (2009) Loss of tight junction barrier function and its role in cancer metastasis. Biochim. Biophys. Acta, 1788, 872-891.
40. Miller, L. D. et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA, 102, 13550-13555.
41. Pawitan, Y. et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res., 7, R953-R964.
42. Perez-Diez, A. et al. (2007) Microarrays for cancer diagnosis and classification. Adv. Exp. Med. Biol., 593, 74-85.
43. Su, J. et al. (2009) Accurate and reliable cancer classification based on probabilistic inference of pathway activity. PLoS One, 4, e8161.
44. Tsuchiya, M. et al. (2010) Gene expression in nontumoral liver tissue and recurrencefree survival in hepatitis C virus-positive hepatocellular carcinoma. Mol. Cancer, 9, 74.
45. van 't Veer, L. J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
46. Wang, W. et al. (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res., 64, 8585-8594.
47. Wang, Y. et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365, 671-679.
48. Weigel, M. T. and Dowsett, M. (2010) Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr. Relat. Cancer, 17, R245-R262.
49. Wright, C. et al. (1989) Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res., 49, 2087-2090.
50. Yamaguchi, H. and Condeelis, J. (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta, 1773, 642-652.
51. Yang, R. et al. (2012) Core module biomarker identification with network exploration for breast cancer metastasis. BMC Bioinformatics, 13, 12.
52. Yu, K. et al. (2008) A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet., 4, e1000129.
53. Zhang, G. et al. (2011) Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions. Cancer Sci., 102, 1216-1222.